肿瘤第一线 · 学术知识传播

订阅

MedSci主页 / 所有栏目 / 肿瘤第一线 · 学术知识传播

宫颈腺鳞癌 45 例临床分析

2021-11-24 吴裕中 吴裕中

妇科肿瘤资讯阅读

分析宫颈腺鳞癌患者的临床特点、治疗方式 ，探讨临床病理参数与患者预后的相关性 。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1408320, encodeId=8579140832010, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Fri Nov 26 07:48:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484695, encodeId=3c66148469507, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102944, encryptionId=3502102944e7, topicName=鳞癌)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20171006/a73877485ccdf6add82293e671bebe21.jpg, createdBy=745a7977375, createdName=1696533704_45270456, createdTime=Fri Nov 26 07:48:21 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2021-11-26 一闲

    #宫颈#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1408320, encodeId=8579140832010, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Fri Nov 26 07:48:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484695, encodeId=3c66148469507, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102944, encryptionId=3502102944e7, topicName=鳞癌)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20171006/a73877485ccdf6add82293e671bebe21.jpg, createdBy=745a7977375, createdName=1696533704_45270456, createdTime=Fri Nov 26 07:48:21 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2021-11-26 1696533704_45270456

    #鳞癌#

    0

相关资讯

安罗替尼治疗多线化疗后进展晚期卵巢癌的疗效观察

卵巢瘤早期发现率很低即使是行细胞减灭术后辅以化疗的患者复发率非常高。多周期化疗后常出现获得性耐药，反复出现肿瘤复发进展，因此临床中卵巢癌患者经常需要尝试多个化疗方案。对疗耐药的患者分子靶向药物治疗可能

Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro

Ovarian cancer is a highly metastatic malignancy and a leading cause of cancer-related death in post

miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1

This study aimed to explore the roles of miRNA-34a (miR-34a) in ovarian cancer (OC) cells and uncove

Clinical outcomes observation in stage IIB–IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy

Cervical cancer is a worldwide major public health issue.It is the second most common malignancy in

New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌

PRIMA研究：前瞻性、全人群、独立盲法评估III期研究

Brit J Cancer：生命早期体重指数和乳腺癌、子宫内膜癌和卵巢癌风险的关系

对于生命早期肥胖，该研究的数据支持其与乳腺癌呈负相关，但与卵巢癌和子宫内膜癌风险呈正相关。